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Imagine trying to stuff about
10,000 miles of spaghetti inside a
basketball. Then, if that was not
difficult enough, attempt to find a
unique one inch segment of pasta
from the middle of this mess, or
try to duplicate, untangle and
separate individual strings to
opposite ends. This simple
analogy illustrates some of the
daunting tasks associated with
the transcription, repair and
replication of the nearly 2 meters
of DNA that is packaged into the
confines of a tiny eukaryotic
nucleus. The solution to each of
these problems lies in the
assembly of the eukaryotic
genome into chromatin, a
structural polymer that not only
solves the basic packaging
problem, but also provides a
dynamic platform that controls all
DNA-mediated processes within
the nucleus.
The basic unit of chromatin is
the nucleosome core particle,
which contains 147 bp of DNA
wrapped nearly twice around an
octamer of the core histones. The
histone octamer is composed of a
central heterotetramer of histones
H3 and H4, flanked by two
heterodimers of histones H2A and
H2B. Each nucleosome is
separated by 10–60 bp of ‘linker’
DNA, and the resulting
nucleosomal array constitutes a
chromatin fiber of ~10 nm in
diameter. This simple ‘beads-on-
a-string’ arrangement is folded
into more condensed, ~30 nm
thick fibers that are stabilized by
binding of a linker histone to each
nucleosome core (note that linker
histones are not related in
sequence to the core histones).
Such 30 nm fibers are then further
condensed in vivo to form
100–400 nm thick interphase
fibers or the more highly
compacted metaphase
chromosome structures. This
organization of DNA into
chromatin fibers hinders its
accessibility to proteins that must
‘read’ and/or copy the nucleotide
base sequence, and consequently
such structures must be dynamic
and capable of regulated
unfolding–folding transitions.
Each of the core histones has a
related globular domain that
mediates histone–histone
interactions within the octamer,
and that organizes the two wraps
of nucleosomal DNA. Each
histone also harbors an amino-
terminal 20–35 residue segment
that is rich in basic amino acids
and extends from the surface of
the nucleosome; histone H2A is
unique in having an additional ~37
amino acid carboxy-terminal
domain that protrudes from the
nucleosome. These histone ‘tails’
do not contribute significantly to
the structure of individual
nucleosomes nor to their stability,
but they do play an essential role
in controlling the folding of
nucleosomal arrays into higher-
order structures. Indeed, in vitro
removal of the histone tails results
in nucleosomal arrays that cannot
condense past the beads-on-a-
string 10 nm fiber. Although the
highly basic histone tails are
generally viewed as DNA-binding
modules, their essential roles in
tail-mediated chromatin folding
also involve inter-nucleosomal
histone–histone interactions.
Post-translational modifications
of histones: encoding or
patterning?
Histones are subject to an
enormous number of post-
translational modifications,
including acetylation and
methylation of lysines (K) and
arginines (R), phosphorylation of
serines (S) and threonines (T),
ubiquitylation and sumoylation of
lysines, as well as ribosylation
(Figure 1; Table 1). Adding to the
complexity is the fact that each
lysine residue can accept one, two
or even three methyl groups, and
an arginine can be either mono- or
di-methylated. The majority of
these post-translational marks
occur on the amino-terminal and
carboxy-terminal histone tail
domains, although more and more
examples of modifications within
the central domains of the
histones have been identified
(Figure 1). Given the number of
new modification sites that are
identified each year, it seems
likely that nearly every histone
residue that is accessible to
solvent may be a target for post-
translational modification.
Why should histones be the
target for so much enzymatic
activity? Given that chromatin is
the physiological template for all
DNA-mediated processes, histone
modifications are likely to control
the structure and/or function of
the chromatin fiber, with different
modifications yielding distinct
functional consequences. Indeed,
recent studies have shown that
site-specific combinations of
histone modifications correlate
well with particular biological
functions (see Table 1). For
instance, the combination of H4
K8 acetylation, H3 K14
acetylation, and H3 S10
phosphorylation is often
associated with transcription.
Conversely, tri-methylation of H3
K9 and the lack of H3 and H4
acetylation correlates with
transcriptional repression in
higher eukaryotes. Particular
patterns of histone modifications
also correlate with global
chromatin dynamics, as
diacetylation of histone H4 at K4
and K12 is associated with
histone deposition at S phase,
and phosphorylation of histone
H2A (at S1 and T119) and H3 (at
T3, S10 and S28) appear to be
hallmarks of condensed mitotic
chromatin.
These and other observations
have led to the idea of a histone
modification ‘code’ which might
be read by various cellular
machineries. The term ‘code’ may
be a misnomer, however, as it
implies that a particular
combination of histone marks will
always dictate the same biological
function. By analogy, the genetic
code is always the same no
matter which gene is analyzed, in
any cell type or tissue: TAG
always means STOP. In the case
of histone modifications, however,
there are clear exceptions — a
particular mark or set of marks
can have different or even
opposite biological
consequences. For instance, the
generally inhibitory H3 K9
methylation can in some cases be
associated with actively
transcribed genes, and histone
acetylation can be inhibitory
rather than stimulatory for
transcription. Thus, rather than a
histone code there are instead
clear patterns of histone marks
that can be differentially
interpreted by cellular factors,
depending on the gene being
studied and the cellular context.
Patterning chromatin: targeting
the enzymes
Although histone modifications
have been studied for over 30
years, the identification of the
histone modifying enzymes
themselves remained elusive until
the first nuclear histone
acetyltransferase (HAT), a
Tetrahymena homolog of yeast
Gcn5, was identified in 1996. In
vivo studies in yeast had
previously characterized Gcn5 as
a transcriptional co-activator
protein, and thus its identification
as a HAT solidified the view that
histone modifications directly
regulate transcription.
Subsequently, a variety of other
transcriptional co-activators,
such as CBP/p300 were found to
have intrinsic HAT activity, and
many co-repressors, such as
Rpd3, were found to have histone
deacetylation (HDAC) activity.
Histone modification enzymes
are now organized into large
HAT, HDAC, histone
methyltransferase (HMT) and
histone kinase families 
(see Table 1).
The precise combination of
locus-specific histone
modifications is due to the
combined effects of targeting
histone modifying enzymes to
specific loci, as well as to the
inherent substrate specificity of
the enzymes themselves. In the
case of transcription, it is clear
that targeting of histone
modifications is achieved by
direct interactions between
histone modifying enzymes and
DNA sequence-specific
transcriptional regulators. For
instance, the yeast HAT complex
SAGA interacts with the
transcriptional activation
domains of a variety of yeast
gene-specific activator proteins,
and these interactions target HAT
activity to specific promoter
regions in vivo. Likewise,
unliganded nuclear hormone
receptors interact with HDAC
complexes, such as NCoR and
SMRT, which direct histone
deacetylase activity to target
genes and contribute to
subsequent gene repression. In
addition to targeting via gene-
specific regulators, the yeast
Set1 and Set2 HMTs are found
associated with RNA polymerase
II holoenzymes, directing histone
H3 K4 or K36 methylation,
respectively, during
transcriptional elongation.
Targeting histone modifications
is not unique to transcriptional
control, as DNA repair and
centromeric heterochromatin use
distinct mechanisms to generate
novel patterns of histone marks.
In the case of DNA repair, the
DNA lesion itself seems to play a
central role in targeting histone
modifications. For instance, the
DNA damage checkpoint kinase
ATM (Mec1p in yeast) is recruited
to a DNA double strand break
where it phosphorylates histone
H2A (in yeast) or the histone H2A
variant, H2AX (in mammals).
Likewise, the human STAGA HAT
complex contains DNA binding
subunits that recognize DNA
backbone-distorting base
adducts, targeting histone H3
acetylation activity to sites of
nucleotide excision repair.
A quite different strategy uses
small noncoding RNAs to target
histone H3 K9 methylation to
chromatin surrounding
mammalian and fission yeast
centromeres. These centromeric
regions are characterized by
repetitive DNA sequences that
are transcribed at low levels. The
resulting double-stranded RNAs
provide substrates for processing
by the RNA interference (RNAi)
machinery which produces small,
21–23 nucleotide RNAs. Recent
studies have shown that an intact
RNAi pathway is essential for
targeting H3 K9 methylation to
centromeric chromatin, and
furthermore that these small
RNAs actually associate with
several chromatin components.
The resulting novel
ribonucleoprotein complex
ultimately targets the Clr4p HMT
to centromeric repeats, via either
RNA–RNA (nascent centromeric
transcripts) or RNA–DNA
homologous pairing. Subsequent
histone methylation leads to
recruitment of proteins such as
Heterochromatin Protein 1 (HP1),
which directs formation of highly
condensed, heterochromatin
structures required for
centromere function.
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Figure 1. Post-translational modifications of the core histones. 
The colored shapes represent known post-translational modifications of the core his-
tones. The histone tails can be methylated at lysines and arginines (green pentagons),
phosphorylated at serines or threonines (yellow circles), ubiquitylated (blue stars) and
acetylated (red triangles) at lysines.
Current Biology
PP
H3       NH2- A R T K Q T A R K S T G G K A P R K Q L A S K A A R K S A ... G V K K ... E F K T D ...  
2 3 4 9 10 11 14 1718 23 262728 36 79
Me
Me
H2A       Ac- S G R G K Q G G K A R A ... A V L L P K K T E S H H K A K G K -COOH 
P
1 5 119
H2B    NH2- P E P V K S A P V P K K G S K K A I N K ... V K Y T S S K -COOH 
5 12 14 15 20 120 (123 in yeast)
H4          Ac- S G R G K G G K G L G K G G A K R H R K V L R D N I Q G I T ...
1 3 5 8 12 16 20
P
UbAc
P
PP
Ac Ac Ac Ac
AcAcAcAcAcAc
Ac Ac Ac Ac
Ub
Me
Me Me
Me
Me Me
Me Me
Current Biology Vol 14 No 14
R548
Table 1. A current view of histone modifications.
Modification Histone Site Enzyme Possible function
Acetylation H2A K4 (S. cerevisiae) Esa1 Transcriptional activation
K5 (mammals) Tip60 Transcriptional activation
p300/CBP Transcriptional activation
K7 (S. cerevisiae) Hat1 ?
Esa1 Transcriptional activation
H2B K5 ATF2 Transcriptional activation
K11 (S. cerevisiae) Gcn5 Transcriptional activation
K12 (mammals) p300/CBP Transcriptional activation
ATF2 Transcriptional activation
K16 (S. cerevisiae) Gcn5 Transcriptional activation
Esa1
K15 (mammals) p300/CBP
ATF2 Transcriptional activation
K20 p300 Transcriptional activation
H3 K4 Esa1 Transcriptional activation
Hpa2 ?
K9 ? Histone deposition
Gcn5 Transcriptional activation
SRC-1 Transcriptional activation
K14 Gcn5, PCAF Transcriptional activation
Esa1, Tip60 Transcriptional activation
DNA repair
SRC-1 Transcriptional activation
Elp3 Transcription elongation
Hpa2 ?
hTFIIIC90 RNA polymerase III transcription
TAF1 RNA polymerase II transcription
Sas2 Euchromatin?
Sas3 Transcriptional activation/elongation?
p300 Transcriptional activation
K18 Gcn5 (SAGA/STAGA complex) Transcriptional activation
DNA repair
p300, CBP DNA replication
Transcriptional activation
K23 Gcn5 (SAGA/STAGA complex) Transcriptional activation
Sas3 DNA repair
p300, CBP Transcriptional activation/elongation?
Transcriptional activation
K27 Gcn5 Transcriptional activation
H4 K5 Hat1 Histone deposition
Esa1, Tip60 Transcriptional activation
DNA repair
ATF2 Transcriptional activation
Hpa2 ?
p300 Transcriptional activation
K8 Gcn5, PCAF Transcriptional activation
Esa1, Tip60 Transcriptional activation
DNA repair
ATF2 Transcriptional activation
Elp3 Transcription elongation
p300 Transcriptional activation
K12 Hat1 Histone deposition
Telomeric silencing
Esa1, Tip60 Transcriptional activation
DNA repair
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Table 1. A current view of histone modifications (continued).
Modification Histone Site Enzyme Possible Function
K12 Hpa2 ?
K16 Gcn5 Transcriptional activation
MOF (D. melanogaster) Transcriptional activation
Transcriptional activation
Esa1 (yeast), Tip60 (mammals) DNA repair
ATF2 Transcriptional activation
Sas2 Euchromatin
Methylation H3 K4 Set1 (yeast) Permissive euchromatin (di-Me)
Set9 (vertebrates) Active euchromatin (tri-Me)
Transcriptional elongation/memory (tri-Me)
Transcriptional activation
MLL, Trx Transcriptional activation
Ash1 (D. melanogaster) Transcriptional activation
K9 Suv39h, Clr4 Transcriptional silencing (tri-Me)
DNA methylation (tri-Me)
G9a Transcriptional repression
Imprinting
SETDB1 Transcriptional repression (tri-Me)
Dim-5, Kryptonite DNA methylation (tri-Me)
Ash1 (D. melanogaster) Transcriptional activation
R17 CARM1 Transcriptional activation
K27 Ezh2 Transcriptional silencing
X inactivation (tri-Me)
K36 Set2 Transcriptional elongation
Transcriptional repression?
K79 Dot1p Euchromatin
Transcriptional elongation / memory
H4 R3 PRMT1 Transcriptional activation
K20 PR-Set7 Transcriptional silencing (mono-Me)
Suv4-20h Heterochromatin (tri-Me)
Ash1 (D. melanogaster) Transcriptional activation
K59 ? Transcriptional silencing?
Phosphorylation H2A S1 ? Mitosis
? Chromatin assembly?
MSK1 Transcriptional repression
T119 NHK-1 Mitosis
S129 (S. cerevisiae) Mec1 DNA repair
S139 (mammalian H2AX) ATR, ATM, DNA-PK DNA repair
H2B S14 (vertebrates) Mst1 Apoptosis
S33 (D. melanogaster) TAF1 Transcriptional activation
H3 T3 ? Mitosis
S10 Aurora-B kinase Mitosis, meiosis
MSK1, MSK2 Immediate-early activation
Snf1 Transcriptional activation
T11 (mammals) Dlk/ZIP Mitosis
S28 (mammals) Aurora-B kinase? Mitosis
MSK1, MSK2 Immediate-early activation
H4 S1 ? Mitosis
Ubiquitylation H2A K119 (mammals) HR6A,B? Spermatogenesis
H2B K120 (mammals) HR6A,B? Meiosis
K123 (S. cerevisiae) Rad6 Transcriptional activation
Euchromatin
H3 ? ? Spermatogenesis
Sumoylation H4 ? Ubc9 Transcriptional repression
Overlaid on top of these locus-
specific marks is the genome-
wide, bulk chromatin
modifications that may control the
day-to-day folding dynamics of
chromosomes. For instance,
newly synthesized histones that
are deposited after passage of
replication forks in S phase are
enriched in acetylated isoforms of
histones H3 and H4, and the
formation of condensed
chromosomes in mitosis is
associated with phosphorylation
of histones H3 and H2A.
In addition to these marks
linked to the cell cycle, there
appears to be a constant battle
among HATs and HDACs on a
global, nontargeted level that
maintains a baseline, equilibrium
level of histone acetylation
throughout the genome. Histone
deacetylase inhibitors, such as
trichostatin or sodium butyrate,
disrupt this equilibrium, leading to
a general increase in bulk histone
acetylation. Such genome-wide
activities of histone modifying
enzymes likely act in concert with
the cell-cycle-linked changes in
bulk chromatin to enhance the
general dynamic nature of
eukaryotic chromosomes.
Patterning chromatin: controlling
enzyme substrate specificity
Recruitment of a histone
modifying enzyme to the right
place at the right time is only the
first step in establishing a
combination of histone marks that
may direct a biological outcome.
The second step in this process
revolves around the specificity of
the enzyme for individual histone
tails and for specific histone
residues (Table 1). For example,
yeast and human Gcn5 and
human PCAF preferentially
acetylate lysine residues within
the histone H3 amino-terminal tail,
at K9 and K14. In contrast, the
yeast and human NuA4 HAT
complexes preferentially acetylate
K4, K8, K12 and K16 of histone
H4. Even more extreme specificity
is seen with HMTs. For instance,
the HMT Set7/9 is restricted to
mono-methylation of histone H3
at K4, whereas the Dim-5 HMT is
a tri-methylase specific for H3 K9.
Thus, recruitment of different
HATs or HMTs can result in
distinct combinations of histone
modifications.
Cross-talk among different
histone marks can also have a
profound effect on enzyme
activity. For instance,
ubiquitylation of H2B K123 by the
E2 ubiquitin conjugating enzyme
Rad6 is required for subsequent
di-methylation of H3 K4 by Set1p
or H3 K79 by Dot1p. Prior histone
marks can also inhibit subsequent
modifications. For instance, H3
S10 phosphorylation inhibits
subsequent H3 K9 methylation,
and of course H3 K9 methylation
can also block acetylation of this
same residue. An excellent
example of even more complex
cross-talk is exemplified during
p53-dependent transcriptional
activation in vitro. In this case
methylation of H4 R3 by protein
arginine methyltransferase 1
(PRMT1) stimulates CBP-p300
acetylation of H4 K5, K8, K12 and
K16, which in turn promotes the
methylation of H3 R2, R17 and
R26 by another PRMT family
member, CARM1. Thus, positive
and negative crosstalk ultimately
generates the complex patterns of
gene or locus-specific histone
marks associated with distinct
chromatin states.
Patterns of histone
modifications: what happens
next?
Once a pattern of histone
modifications is established at a
target locus, what do they do?
Many older models proposed that
histone modifications might
directly influence either the
structure of individual
nucleosomes or the folding
dynamics of nucleosomal arrays.
Indeed one common
misconception is that histone
modifications that alter the charge
of a residue, such as lysine
acetylation or serine
phosphorylation, will disrupt
histone–DNA interactions leading
to ‘open’ or ‘active’ chromatin
structures. There is not actually
much evidence for such models.
For example, the histone H3 tail
contains 13 positively charged
amino acids, and thus acetylation
of one to four residues will only
yield a 10–30% decrease in
positive charge, levels that are
unlikely to perturb ionic
interactions with DNA. 
Consistent with this view, in
vivo laser crosslinking studies
have shown that histone
hyperacetylation does not release
tails from DNA, and nucleosomes
that harbor >12 acetates per
octamer wrap DNA normally in
vitro and have hydrodynamic
properties that are nearly identical
to unmodified nucleosomes.
Although it is true that histone
hyperacetylation does disrupt the
folding dynamics of nucleosomal
arrays in vitro, even in this case
6–12 acetates per nucleosome are
required. Although most site-
specific patterns of histone
modifications have yet to be
generated and tested in vitro, the
prevailing view is that these
histone marks may not alter
nucleosomal dynamics by
themselves.
In contrast to the lack of
evidence pointing to direct
changes in chromatin structure,
there is now a wealth of examples
where specific histone
modifications control the binding
of nonhistone proteins to the
chromatin fiber. These nonhistone
proteins then elicit the function
that is associated with a particular
histone mark. A hallmark of many
proteins that bind to histone tails
is the presence of small histone
binding modules. For example,
some chromodomains bind to
methylated lysines, whereas
bromodomains specify binding to
acetylated lysines. Furthermore,
these modules often bind to only
a particular modified histone
residue. For example, the
chromodomain within HP1
interacts specifically with a
dimethylated K9 of histone H3,
whereas the chromodomain of the
Polycomb protein binds to a
dimethylated K27 of histone H3.
In contrast, the binding of
bromodomains to different
acetylated lysines does not show
as much specificity. For instance,
acetylation of K8 within histone
H4 can promote the recruitment
of the ATP-dependent chromatin
remodeling enzyme, human
SWI/SNF — via a bromodomain
within the Brg1 subunit — but a
similar bromodomain within the
Swi2 subunit of the yeast
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SWI/SNF complex interacts with a
broader range of acetylated H3
and H4 tails. 
The interactions of
bromodomains and
chromodomains with modified
tails is also subject to
modification crosstalk — the
modification of adjacent residues
can positively or negatively
regulate binding. Thus, in many
ways histone tails can be viewed
as complex protein–protein
interaction surfaces that are
regulated by numerous post-
translational modifications.
Furthermore, it is clear that the
overall constellation of proteins
bound to each tail plays a primary
role in dictating the biological
functions of that chromatin
domain.
Chromatin fiber heterogeneity:
histone variants
Throughout this primer we have
described chromatin (in its
simplest form) as a linear array of
canonical nucleosomes. An in vivo
chromatin fiber, however, is
actually an extremely
heterogeneous nucleoprotein
filament, even at the nucleosome
level. First and foremost, in
addition to canonical
nucleosomes, in vivo chromatin
arrays also contain novel types of
nucleosome that harbor one or
more variant isoforms of the core
histones. For instance,
nucleosomes assembled at yeast
and mammalian centromeres
contain a histone H3 variant,
Cse4/CENP-A, which is essential
for centromere function or
assembly. Another histone H3
variant, H3.3, replaces canonical
histone H3 during transcription,
generating a mark of the
transcription event. Several
variants of histone H2A have also
been identified. The macro-H2A
variant is restricted to metazoans
and functions in X chromosome
inactivation, while H2AZ (also
known as H2A.F/Z or H2AvD) is
found in all eukaryotes.
Surprisingly, H2AZ is required for
one or more essential roles in
chromatin structure that cannot
be replaced by bona fide histone
H2A.
In most cases, how histone
variants alter nucleosome
structure or change the folding
properties of nucleosomal arrays
is not known. It is also not clear
how many of these variant
nucleosomes are localized to
specific DNA sequences; for
example, why are CENP-A-
containing nucleosomes found
only at centromeres? Notable
exceptions include the deposition
of H3.3 to chromatin of RNA
polymerase II transcribed genes
via a novel replication-
independent assembly complex,
and the exchange of H2AZ for
canonical H2A via the ATP-
dependent SWR1 complex. 
Once a histone variant is
targeted to a specific locus, there
is the potential for creation of
novel chromatin domains that
have distinct regulatory
properties. For instance, the
amino-terminal tail of CENP-A
lacks the phosphorylation and
acetylation sites that are normally
modified in histone H3 at
transcriptionally active regions.
Thus, CENP-A might produce
islands of unmodified histone H3
that help to maintain centromeric
chromatin in its condensed,
inactive state. In contrast, the
histone H3.3 variant contains an
amino-terminal tail that is virtually
identical to that of histone H3, and
thus it seems likely that many of
the transcription-associated
marks that have been attributed to
histone H3 are likely also
occurring on the histone H3.3
variant. 
In the case of H2AZ,
biochemical studies suggest that
nucleosomal arrays containing
H2AZ may only partially compact,
resisting formation of large
100–400 nm fibers and thereby
facilitating transcription. Thus,
incorporation of histone variants
into chromatin fibers might
enhance chromosome dynamics
by creating domains of chromatin
with novel properties.
Concluding remarks
Histone variants, distinct patterns
of posttranslational modifications
of histones, and histone tail
binding proteins all contribute to
establishment of various ‘open’ or
‘closed’ chromatin domains that
have specialized folding
properties and biological
functions. Some of these domains
can be propagated through DNA
replication and mitosis,
guaranteeing the inheritance of
chromatin states to progeny.
Histone lysine methylation may
play a central role in the stability
of these chromatin states, as to
date no enzymes are known that
catalyze lysine demethylation.
Furthermore, several nonhistone
proteins, such as HP1 or the
PRC1 polycomb complex, not
only bind to methylated histone
lysines, but also recruit the
methylase itself, thus providing a
means for templating new histone
methylation events — for
example, following replication
fork passage — or for spreading
the domain to adjacent
nucleosomes. 
How ‘open’ states are
propagated through cell divisions
is not clear, especially as histone
lysine acetylation or serine
phosphorylation can be rapidly
reversed by HDACs or histone
phosphatases. Future studies will
no doubt continue to identify the
functional and biochemical
properties of new chromatin
domains as well as to elucidate
the principles that govern their
maintenance and propagation.
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